Other researchers found that increased levels of ROS, whose production is enhanced in endothelial dysfunction, upregulates iNOS and eNOS expression in human coronary artery endothelial cells (HCAECs) both in vitro and in vivo. This evidence concerns the gene NOS3 and endothelial dysfunction.